Maria Jose Ruiz Castrillo

Mrs. Maria Jose Ruiz Castrillo


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
LPLeonardo Portocarrero-Sánchez
Leonardo Portocarrero-Sánchez
AGAlfonso Gil-Martínez
Alfonso Gil-Martínez
JSJose F. Paz Solis
Jose F. Paz Solis
MRMaría Román-Aragón
María Román-Aragón
BMBeatriz Mansilla-Fernández
Beatriz Mansilla-Fernández
JDJavier Díaz-de-Terán
Javier Díaz-de-Terán
Background: Occipital nerve stimulation (ONS) is an effective therapy for patients with refractory chronic cluster headache (rCCH); however, it is not without complications, and to date, there are no conclusive findings regarding factors that would allow the prediction of treatment response. The primary objective of this study is to identify such factors to improve patient selection. Methods: This single-center prospective observational study will be conducted at the Department of Neurology, Hospital Universitario La Paz (Madrid, Spain). Given the low prevalence of rCCH, a convenience sampling approach will be adopted, with an expected enrollment of a minimum of 15 patients over 24 months of the study. The study is structured into three periods: Pre-ONS (pre-implantation), ONS (implantation), and Post-ONS (follow-up at 12 months). During the pre-implantation phase, patients will undergo a multidimensional assessment encompassing structural 3T brain magnetic resonance imaging (MRI), blood analysis (calcitonin gene-related peptide (CGRP), pituitary adenylate cyclase-activating peptide 38 (PACAP38), and vasoactive intestinal peptide (VIP)), neuropsychological evaluation, auditory evoked potentials, algometry (pressure pain threshold, temporal summation, conditioned pain modulation), and transcutaneous electrical nerve stimulation (TENS). Follow-up visits will be conducted at 3, 6, and 12 months post-implantation. Results: This study aims to identify biomarkers or their combinations capable of reliably predicting patients who would benefit from ONS. Conclusions: Through this multidimensional assessment, this study seeks to identify predictive factors of response to ONS, thereby improving patient selection, optimizing healthcare resources, and advancing the understanding of treatment response mechanisms.

10 October 2026 in Nursing Reports
Verified
Journal Article
Open access
PDF file
MCMaria Jose Ruiz Castrillo
Maria Jose Ruiz Castrillo
LPLeonardo Portocarrero-Sánchez
Leonardo Portocarrero-Sánchez
LZLucía Zaballa-Pérez
Lucía Zaballa-Pérez
ASAlejandro Sánchez-Huertas
Alejandro Sánchez-Huertas
JDJavier Díaz-de-Terán
Javier Díaz-de-Terán
Background/Objectives: Migraine is a leading cause of disability worldwide. Despite advances such as calcitonin gene-related peptide (CGRP)-targeted therapies, suboptimal treatment adherence, limited health literacy, and weak self-management remain common, and patient-reported data on the contribution of specialist headache nurses within European tertiary units are scarce. This study describes patient-reported adherence to acute treatment and to lifestyle recommendations, self-perceived knowledge, and perceived quality of life in adults with migraine who had attended a structured, nurse-led educational consultation in a tertiary multidisciplinary headache unit. Methods: This cross-sectional descriptive study included 90 adults (≥18 years) with migraine diagnosed according to the International Classification of Headache Disorders, third edition (ICHD-3), who were starting treatment with an anti-CGRP monoclonal antibody and consecutively attended a specialist nursing consultation; patients with documented cognitive impairment or without written informed consent were excluded. Between January and December 2021, participants completed, on a single occasion after the consultation, an electronic, structured, piloted ad hoc survey covering knowledge (with pre-consultation knowledge rated retrospectively), adherence to pharmacological and lifestyle recommendations, perceived changes in attack frequency and intensity, and self-reported quality of life. Data were analysed descriptively, with 95% confidence intervals (CIs) for proportions and without formal hypothesis testing. Results: Participants were mostly women (67.8%), with a mean age of 43.1 ± 10.7 years. Overall, 74.4% (95% CI 64.6–82.3) reported always following acute-treatment instructions and 66.7% (56.4–75.5) always following lifestyle recommendations; 68.9% (58.7–77.5) felt the education had improved their understanding of migraine and their quality of life, and 67.8% (57.6–76.5) perceived fewer attacks. Self-rated adequate knowledge was higher at the time of the survey than retrospectively recalled for the pre-consultation period in all five domains. The main barriers were limited prior knowledge and difficulty maintaining a headache diary. Conclusions: Most patients who had received structured nurse-led education reported good adherence and perceived benefits in their understanding of migraine and quality of life. Given the cross-sectional design, the retrospective assessment of prior knowledge, the use of a non-validated questionnaire, and the absence of a control group, these findings cannot be attributed to the consultation itself, and perceived changes in attack frequency cannot be separated from the effect of the newly started anti-CGRP treatment; prospective, controlled studies using validated outcome measures are needed. This study was not registered.